Curtis Wright | |
|---|---|
| Born | 1949 (age 74–75) |
| Academic background | |
| Education | Haverford College (BS) George Washington University (MD) Johns Hopkins University (MPH) |
| Academic work | |
| Discipline | Medicine |
| Sub-discipline | Pharmacology Health policy Drug policy |
| Institutions | Tufts University Food and Drug Administration Purdue Pharma |
Curtis Wright IV (born in 1949) is an American former government official known for his role in the Food and Drug Administration's approval of OxyContin for Purdue Pharma in 1995, followed by his subsequent employment by the company, which led to portrayals in films and reports in nonfiction books, magazines, and news media outlets of his alleged role as one of the key figures in the current opioid epidemic in the United States. Wright was implicated in a criminal conspiracy outlined in a 2006 United States Department of Justice review document that was first made public in Purdue Pharma's 2019 bankruptcy proceedings. Although that case was settled in a 2007 plea agreement deal, members of United States Congress have requested the full 2006 documentation from the Department of Justice with the goal of opening a new case based upon the evidence then gathered.[1] Parts of Wright's sworn depositions in 2003 and 2018 have internal contradictions and differ from documentary evidence described the 2003–2006 U.S. Federal Government investigation into Purdue Pharma.